This review highlights the central role of altered energy metabolism and subsequent ROS overproduction in the pathogenesis of diabetic cardiomyopathy, providing mechanistic insights for potential therapeutic targets.
Answers are grounded in this paper and cite their sources.
Should not change diabetic cardiomyopathy management; leaves open whether targeting fatty acid oxidation improves outcomes.
Diabetic cardiomyopathy is initiated by alterations in energy substrates. Despite excess of plasma glucose and lipids, the diabetic heart almost exclusively depends on fatty acid degradation. Glycolytic enzymes and transporters are impaired by fatty acid metabolism, leading to accumulation of glucose derivatives. However, fatty acid oxidation yields lower ATP production per mole of oxygen than glucose, causing mitochondrial uncoupling and decreased energy efficiency. In addition, the oxidation of fatty acids can saturate and cause their deposition in the cytosol, where they deviate to induce toxic metabolites or gene expression by nuclear-receptor interaction. Hyperglycemia, the fatty acid oxidation pathway, and the cytosolic storage of fatty acid and glucose/fatty acid derivatives are major inducers of reactive oxygen species. However, the presence of these species can be essential for physiological responses in the diabetic myocardium.
No takes yet. Share an insight, caveat, or question.
Lorenzo et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: